Clinical trial
Treatment of Children With Insufficient Secretion of Growth Hormone
NCT00271518 · LG Life Sciences, Industry · Unknown status
Key facts
| NCT number | NCT00271518 |
|---|---|
| Title | Treatment of Children With Insufficient Secretion of Growth Hormone |
| Official title | A Phase III, Multi-centre, Randomised, Parallel Group Study of Safety and Efficacy of the LB03002 a New Sustained Release Formulation of Human Recombinant Growth Hormone as Compared to Standard Daily Therapy in Treatment Naive Children With Growth Failure Due to Insufficient Secretion of Endogenous… |
| Acronym | BPLG-004 |
| Lead sponsor | LG Life Sciences, Industry |
| Collaborators | BioPartners GmbH Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Growth Hormone Deficiency (GHD) |
| Intervention type | Drug |
| Interventions | growth hormone (somatropin) |
| Enrollment | 144 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2013 |
| First posted | Jan 2, 2006 |
| Last update posted | Mar 17, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: